To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Adam Schechter successfully led ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The leader of the Triad’s ...

Andrew Cecere is the most enduring and institutionally committed chief executive in the history of US Bancorp.

CEO Adam Schechter highlighted a 5% revenue growth for Q1 2025, with Diagnostics Laboratories achieving a 6% increase. This growth was attributed to rebounding volumes and strong managed care access.

COVID-19 tests took off, first, at testing sites — and later at home, Labcorp (LH) CEO Adam Schechter told Yahoo Finance at the 2022 All Markets Summit. In fact, Labcorp, one of the leading testing ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

BURLINGTON, N.C., Feb. 1, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has once again been named to FORTUNE® magazine's list of the ...

Adam Schechter, chairman and CEO of coronavirus testing giant LabCorp, thinks it's highly unlikely that corporate workplaces will ever return to normal, or to way they were before the pandemic.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

When Adam Schechter took on the role of CEO of Labcorp in November 2019, he had over three decades of experience in the healthcare and pharmaceutical industry. Still, he couldn't have anticipated the ...

Experts are not recommending that Covid vaccine recipients have an antibody test after they are vaccinated, Labcorp CEO Adam Schechter told CNBC on Tuesday. "We still have to understand a lot more ...

The yet-to-be-named new company will be publicly traded. Separating the laboratory testing work of LabCorp from the clinical trial services business, much of which came from acquisitions, will enable ...